Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

37.95
BATS BZX Real-Time Price
As of 1:27pm ET
 +1.11 / +3.01%
Today’s Change
15.15
Today|||52-Week Range
38.09
+10.50%
Year-to-Date

Today’s Trading

Previous close36.84
Today’s open36.91
Day’s range36.71 - 38.09
Volume39,764
Average volume (3 months)824,283
Market cap$2.6B
Data as of 1:27pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)-0.64%
Earnings growth (next 5 years)+9.30%
Revenue growth (last year)+2.33%
P/E ratio25.4
Price/Sales2.30
Price/Book3.24

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+0.05+0.06%
NEOGNeogen Corp-0.32-0.54%
IMMUImmunomedics Inc+0.14+0.88%
QDELQuidel Corp-0.46-0.98%
Data as of 1:29pm ET, 01/18/2018

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$0.24
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts